[1] SMITH K,DEUTSCH A J,MCGRAIL C,et al.Multi-ancestry polygenic mechanisms of type 2 diabetes[J]. Nat Med,2024,30(4):1065-1074.
[2] JUNG C H,MOK J O.Recent updates on vascular complications in patients with type 2 diabetes mellitus[J]. Endocrinol Metab,2020,35(2):260-271.
[3] AVIS S R,VERNON S T,HAGSTRÖM E,et al.Coronary artery disease in the absence of traditional risk factors:a call for action[J]. Eur Heart J,2021,42(37):3822-3824.
[4] LEE S E,SUNG J M,ANDREINI D,et al.Association between changes in perivascular adipose tissue density and plaque progression[J]. JACC Cardiovasc Imag,2022,15(10):1760-1767.
[5] LEE Y C,LEE J W,KWON Y J.Comparison of the triglyceride glucose(TyG) index,triglyceride to high-density lipoprotein cholesterol(TG/HDL-C) ratio,and metabolic score for insulin resistance(METS-IR) associated with periodontitis in Korean adults[J]. Ther Adv Chronic Dis,2022,13:20406223221122671.
[6] SI N,SHI K,LI N,et al.Identification of patients with acute myocardial infarction based on coronary CT angiography:the value of pericoronary adipose tissue radiomics[J]. Eur Radiol,2022,32(10):6868-6877.
[7] YAN H,ZHAO N,GENG W,et al.Pericoronary fat attenuation index and coronary plaque quantified from coronary computed tomography angiography identify ischemia-causing lesions[J]. Int J Cardiol,2022,357:8-13.
[8] SCHMIDT A M.Highlighting diabetes mellitus:the epidemic continues[J]. Arterioscler Thromb Vasc Biol,2018,38(1):e1-e8.
[9] 中华医学会糖尿病学分会.中国糖尿病防治指南(2024版)[J]. 中华糖尿病杂志,2025,17(1):16-139.
[10] 秦真真,戚圣香,叶青,等.甘油三酯-葡萄糖指数与肥胖指标的联合作用对老年人群高血压患病风险的影响[J]. 现代医学,2024,52(7):1050-1056.
[11] GUTIÉRREZ-TORRES D S,KIM S,ALBANES D,et al.Changes in smoking use and subsequent lung cancer risk in the alpha-tocopherol,beta-carotene cancer prevention study[J]. J Natl Cancer Inst,2024,116(6):895-901.
[12] 张运,张澄,陈韵岱,等.提高冠状动脉微血管疾病的规范化诊治水平[J]. 中华心血管病杂志,2024,52(6):577-580.
[13] 黄美静,唐兰,舒薪宇,等.甲状腺功能正常的2型糖尿病患者甲状腺激素敏感性指数与冠心病的相关性[J]. 现代医学,2026,54(3):473-482.
[14] YU L,YANG Y X,GONG Z,et al.FcRn-dependent IgG accumulation in adipose tissue unmasks obesity pathophysiology[J]. Cell Metab,2025,37(3):656-672.e7.
[15] INOGUCHI T,LI P,UMEDA F,et al.High glucose level and free fatty acid stimulate reactive oxygen species production through protein kinase C—dependent activation of NAD(P)H oxidase in cultured vascular cells[J]. Diabetes,2000,49(11):1939-1945.
[16] SARKAR P,THIRUMURUGAN K.New insights into TNFα/PTP1B and PPARγ pathway through RNF213-a link between inflammation,obesity,insulin resistance,and Moyamoya disease[J]. Gene,2021,771:145340.
[17] HOSHINO M,YANG S,SUGIYAMA T,et al.Peri-coronary inflammation is associated with findings on coronary computed tomography angiography and fractional flow reserve[J]. J Cardiovasc Comput Tomogr,2020,14(6):483-489.
[18] YANG W,WEN D,LI S,et al.Prognostic value of non-alcoholic fatty liver disease and RCA pericoronary adipose tissue CT attenuation in patients with acute chest pain[J]. Acad Radiol,2024,31(5):1773-1783.
[19] SIASOS G,TSIGKOU V,COSKUN A U,et al.The role of shear stress in coronary artery disease[J]. Curr Top Med Chem,2023,23(22):2132-2157.
[20] LIAO Y,ZHANG R,SHI S,et al.Triglyceride-glucose index linked to all-cause mortality in critically ill patients:a cohort of 3 026 patients[J]. Cardiovasc Diabetol,2022,21(1):128.
[21] OIKONOMOU E K,MARWAN M,DESAI M Y,et al.Non-invasive detection of coronary inflammation using computed tomography and prediction of residual cardiovascular risk(the CRISP CT study):a post-hoc analysis of prospective outcome data[J]. Lancet,2018,392(10151):929-939.
[22] 陈璐琳,杨廷杰,孙猛,等.营养不良与冠状动脉炎症对冠心病患者预后的影响[J]. 实用医学杂志,2025,41(7):1010-1017.
[23] YANG T,LI G,WANG C,et al.Insulin resistance and coronary inflammation in patients with coronary artery disease:a cross-sectional study[J]. Cardiovasc Diabetol,2024,23(1):79.
[24] RIDKER P M,BHATT D L,PRADHAN A D,et al.Inflammation and cholesterol as predictors of cardiovascular events among patients receiving statin therapy:a collaborative analysis of three randomised trials[J]. Lancet,2023,401(10384):1293-1301.
[25] AJALA O N,EVERETT B M.Targeting inflammation to reduce residual cardiovascular risk[J]. Curr Atheroscler Rep,2020,22(11):66.
[26] ANDREADI A,BELLIA A,DI DANIELE N,et al.The molecular link between oxidative stress,insulin resistance,and type 2 diabetes:a target for new therapies against cardiovascular diseases[J]. Curr Opin Pharmacol,2022,62:85-96.
[27] DENIMAL D,BERGAS V,PAIS-DE-BARROS J P,et al.Liraglutide reduces plasma dihydroceramide levels in patients with type 2 diabetes[J]. Cardiovasc Diabetol,2023,22(1):104.
[28] LIU Y,DONG Y,WANG X,et al.Association between metformin treatment and coronary artery inflammation based on pericoronary adipose tissue attenuation in type 2 diabetes mellitus patients[J]. J Clin Hypertens,2024,26(4):330-337.
[29] ZHANG Y,CHEN H,FENG Y,et al.Activation of AMPK by GLP-1R agonists mitigates Alzheimer-related phenotypes in transgenic mice[J]. Nat Aging,2025,5(6):1097-1113.
[30] RECZEK C R,CHAKRABARTY R P,D'ALESSANDRO K B,et al.Metformin targets mitochondrial complex I to lower blood glucose levels[J]. Sci Adv,2024,10(51):eads5466. |